Анализ чувствительности и идентифицируемости математических моделей распространения эпидемии COVID-19
https://doi.org/10.18699/VJ21.010
Аннотация
Об авторах
О. И. КриворотькоРоссия
Новосибирск
С. И. Кабанихин
Россия
Новосибирск
М. И. Сосновская
Россия
Новосибирск
Д. В. Андорная
Россия
Новосибирск
Список литературы
1. Adams B.M., Banks H.T., Davidiana M., Kwona H.D., Trana H.T., Wynnea S.N., Rosenbergb E.S. HIV dynamics: modeling, data analysis, and optimal treatment protocols. J. Comput. Appl. Math. 2004; 184:10-49. DOI 10.1016/j.cam.2005.02.004.
2. Bellu G., Saccomani M.P., Audoly S., D’Angiò L. DAISY: a new software tool to test global identifiability of biological and physiological systems. Comput. Methods Programs Biomed. 2007;88(1):52-61. DOI 10.1016/j.cmpb.2007.07.002.
3. Gomez J., Prieto J., Leon E., Rodriguez A. INFEKTA: a general agent-based model for transmission of infectious diseases: studying the COVID-19 propagation in Bogotá – Colombia. MedRxiv. 2020. DOI 10.1101/2020.04.06.20056119.
4. Habtemariam T., Tameru B., Nganwa D., Beyene G., Ayanwale L., Robnett V. Epidemiologic modeling of HIV/AIDS: use of computational models to study the population dynamics of the disease to assess effective intervention strategies for decision-making. Adv. Syst. Sci. Appl. 2008;8(1):35-39.
5. Kabanikhin S.I. Definitions and examples of inverse and ill-posed problems. J. Inverse Ill-Posed Probl. 2008;16(4):317-357. DOI 10.1515/JIIP.2008.019.
6. Kabanikhin S.I., Voronov D.A., Grodz A.A., Krivorotko O.I. Identifiability of mathematical models in medical biology. Russ. J. Genet. Appl. Res. 2016;6(8):838-844. DOI 10.1134/S2079059716070054.
7. Kermack W.O., McKendrick A.G. A contribution of the mathematical theory of epidemics. Proc. R. Soc. Lond. A. 1927;115:700-721. DOI 10.1098/rspa.1927.0118.
8. Kerr C., Stuart R., Mistry D., Abeysuriya R., Hart G., Rosenfeld K., Selvaraj P., Nunez R., Hagedorn B., George L., Izzo A., Palmer A., Delport D., Bennette C., Wagner B., Chang S., Cohen J., Panovska-Griffiths J., Jastrzebski M., Oron A., Wenger E., Famulare M., Klein D. Covasim: an agent-based model of COVID-19 dynamics and interventions. MedRxiv. 2020. DOI 10.1101/2020.05.10.20097469.
9. Krivorotko O.I., Andornaya D.V., Kabanikhin S.I. Sensitivity analysis and practical identifiability of some mathematical models in biology. J. Appl. Ind. Math. 2020a;14:115-130. DOI 10.1134/S1990478920010123.
10. Krivorotko O.I., Kabanikhin S.I., Zyat’kov N.Yu., Prikhod’ko A.Yu., Prokhoshin N.M., Shishlenin M.A. Mathematical modeling and forecasting of COVID-19 in Moscow and Novosibirsk region. Numer. Analysis Applications. 2020b;13(4):332-348. DOI 10.1134/S1995423920040047.
11. Lauer S.A., Grantz K.H., Bi Q., Jones F.K., Zheng Q., Meredith H., Azman A.S., Reich N.G., Lessler J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med. 2020;172:577-582. DOI 10.7326/m20-0504.
12. Lee W., Liu S., Tembine H., Li W., Osher S. Controlling propagation of epidemics via mean-field games. ArXiv. 2020;arXiv:2006.01249.
13. Likhoshvai V.A., Fadeev S.I., Demidenko G.V., Matushkin Yu.G. Modeling nonbranching multistage synthesis by an equation with retarded argument. Sibirskiy Zhurnal Industrialnoy Matematiki = Journal of Applied and Industrial Mathematics. 2004;7(1):73-94. (in Russian)
14. Miao H., Xia X., Perelson A.S., Wu H. On identifiability of nonlinear ODE models and applications in viral dynamics. SIAM Rev. 2011;53(1):3-39. DOI 10.1137/090757009.
15. Raue A., Becker V., Klingmüller U., Timmer J. Identifiability and observability analysis for experimental design in nonlinear dynamical models. Chaos. 2010;20(4):045105. DOI 10.1063/1.3528102.
16. Raue A., Karlsson J., Saccomani M.P., Jirstrand M., Timmer J. Comparison of approaches for parameter identifiability analysis of biological systems. Bioinformatics. 2014;30(10):1440-1448. DOI 10.1093/bioinformatics/btu006.
17. Tuomisto J.T., Yrjölä J., Kolehmainen M., Bonsdorff J., Pekkanen J., Tikkanen T. An agent-based epidemic model REINA for COVID-19 to identify destructive policies. MedRxiv. 2020. DOI 10.1101/2020.04.09.20047498.
18. Unlu E., Leger H., Motornyi O., Rukubayihunga A., Ishacian T., Chouiten M. Epidemic analysis of COVID-19 outbreak and counter-measures in France. MedRxiv. 2020. DOI 10.1101/2020.04.27.20079962.
19. Verity R., Okell L., Dorigatti I., Winskill P., Whittaker C., Imai N., Cuomo-Dannenburg G., Thompson H., Walker P., Fu H., Dighe A., Griffin J., Baguelin M., Bhatia S., Boonyasiri S., Cori A., Cucunubá Z., FitzJohn R., Gaythorpe K., Green W., Hamlet A., Hinsley W., Laydon D., Nedjati-Gilani G., Riley S., Elsland S., Volz E., Wang H., Wang Y., Xi X., Donnelly C., Ghani A., Ferguson N.M. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect. Dis. 2020;20(6):669-677. DOI 10.1016/S1473-3099(20)30243-7.
20. Voropaeva O.F., Tsgoev Ch.A. A numerical model of inflammation dynamics in the core of myocardial infarction. J. Appl. Ind. Math. 2019;13(2):372-383. DOI 10.1134/S1990478919020182.
21. Wolfram C. An agent-based model of COVID-19. Complex Syst. 2020; 29(1):87-105. DOI 10.25088/ComplexSystems.29.1.87.
22. Wölfel R., Corman V.M., Guggemos W., Seilmaier M., Zange S., Müller M.A., Niemeyer D., Jones T.C., Vollmar P.V., Rothe C., Hoelscher M., Bleicker T., Brünink S., Schneider J., Ehmann R., Zwirglmaier K., Drosten C., Wendtner C. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465-469. DOI 10.1038/s41586-020-2196-x.
23. Yao K.Z., Shaw B.M., Kou B., McAuley K.B., Bacon D.W. Modeling ethylene/butene copoly-merization with multi-site catalysts: parameter estimability and experimental design. Polymer Reaction Engineer. 2003;11(3):563-588. DOI 10.1081/PRE-120024426.